STAT+: Trump boast on drug pricing policy overstated state-level interest in federal program

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Trump boast on drug pricing policy overstated state-level interest in federal programWorldPing
Image via STAT.

What happened

President Trump and his aides boasted that every U.S. state wanted to participate in a drug pricing initiative through Medicaid.

Several states said they weren't sure yet.

Key facts

  • Reported by STAT and published Thu, 24 Sep 2026 08:30:00 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: Trump boast on drug pricing policy overstated state-level interest in federal program

  2. STAT+: Heidi Overton, Trump’s pick for FDA head, to face questions at Senate hearing

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage